sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Colorectal Cancer Screening Market Size & Forecast

Historic: 2022-2024 Base Year: 2025 Forecast: 2026–2033
US$ 20.07 Billion
Market Size 2025 · Base Year
US$ 30.11 Billion
Projected Market Size by 2033
5.20%
CAGR · 2026–2033
SHARE
BMIPUB00037232 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
12
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)
10 +
Major Players
Major companies profiled including F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Exact Sciences Corporation, Guardant Health, Inc.
350
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Growing Awareness of Early Colorectal Cancer Detection

  • Government Screening Programs Supporting Preventive Healthcare

  • Advancements in Non-Invasive Diagnostic Technologies

Where Growth Opportunities Exist

Key Opportunities

  • Expansion Across Emerging Healthcare Markets

  • Growing Adoption of Home-Based Screening Solutions

  • Strategic Collaborations for Diagnostic Innovation

What Could Slow It Down

Market Restraints

  • Limited Screening Participation in Developing Regions

  • High Cost of Advanced Diagnostic Technologies

  • Regulatory Challenges for Novel Screening Methods

Market Segmentation

Coverage by Segment

Type

Stool-based
Colonoscopy
Others

End-user

Hospitals & Clinics
Clinical Laboratories
Diagnostics Imaging Centers
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

F. Hoffmann-La Roche Ltd
Abbott Laboratories
Danaher Corporation
Exact Sciences Corporation
Guardant Health, Inc.
Quest Diagnostics Incorporated
Bio-Rad Laboratories, Inc.
Sysmex Corporation
QIAGEN N.V.
Eiken Chemical Co., Ltd.
What's Inside

Report Scope & Deliverables

Market Size 2025 US$ 20.07 Billion
Market Size 2033 US$ 30.11 Billion
CAGR 2026–2033 5.20%
Segments By Type (Stool-based, Colonoscopy, Others)  |  By End-user (Hospitals & Clinics, Clinical Laboratories, Diagnostics Imaging Centers)
Geographies North America (US, Canada, Mexico)  ·  Europe (Germany, Italy, France, U.K., Spain, Belgium, Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, Czech Republic, Ukraine, Slovakia, Bulgaria)  ·  Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh)  ·  South and Central America (Brazil, Argentina, Chile, Colombia, Peru)  ·  Middle East and Africa (Saudi Arabia, United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00037232
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 350 pages of in-depth Colorectal Cancer Screening Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.